Concepedia

Implications of external price referencing of pharmaceuticals in Middle East countries

Zoltán Kaló, Ibrahim Alabbadi, Ola Ghaleb Al Ahdab, Maryam Alowayesh, Mahmoud Elmahdawy, A.H. Al-Saggabi, V. Tanzi, Daoud Al‐Badriyeh, Hamad S Alsultan, Faleh Mohamed Hussain Ali,

Expert Review of Pharmacoeconomics & Outcomes Research · 2015 · 37 citations · 9 references

DOI

Abstract

Our analysis revealed the importance of population size and EPR implementation on drug price levels; however, EPR results in higher pharmaceutical prices in lower-income countries compared to non-pharmaceutical services.

References

9

Differences in external price referencing in Europe—A descriptive overview

Christine Leopold, Sabine Vogler, A.K. Mantel-Teeuwisse et al. · Health Policy · 2011 · 133 citations

, , +5

Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004?

Helle Håkonsen, Anne Marie Horn, Else‐Lydia Toverud · Health Policy · 2008 · 69 citations

, , +10

Comparative approaches to pharmaceutical price regulation in the European Union.

Monique F. Mrazek · PubMed · 2002 · 67 citations

Impact of Cross-Reference Pricing on Pharmaceutical Prices

Tom Stargardt, Jonas Schrey gg · Applied Health Economics and Health Policy · 2006 · 59 citations

, , +5

Pricing and reimbursement of pharmaceuticals in Italy

Pietro Folino-Gallo, Simona Montilla, Mario Bruzzone et al. · The European Journal of Health Economics · 2008 · 49 citations

, , +8